The US biotechnology market is projected to grow at a significant CAGR of 7.4% during the forecast period (2020-2026). The increasing popularity of cell culture in drug discovery, cancer treatment, and vaccine production has promoted the funding of cell-based research. Decades of investment in research has made the US a world leader in biological and Medical Science. Most of the success is due to the public/private funding partners such as state governments of developed economies have put forward money in the form of initiatives in order to attract cell research so that the states may gain benefits from this promising technology. Private funds generally come from pharmaceutical companies that fund trials to list their own products.
Browse the full report description US Biotechnology Market Size, Share & Trends Analysis Report by Type (Healthcare, Crop Production and Agriculture, Industrial, Natural Resources & Environment, and Others) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/us-biotechnology-market
It has led to the development of innovative technologies and created entirely new global industries. Investment in biomedical research funded by NIH has supported discoveries that lowered death and disability from polio, heart disease, and cancer, prolonging life and reducing suffering. NIH-funded research is continuing to produce the awareness that is needed for improvements in the healthcare sector in the near future. NIH's major research funding was on immunotherapy, which uses human cells to improve cancer treatment options and creating organ-on-a-chip through a series of micro-chambers, fluids, and human cells to stimulate a person’s internal organs. As the funding on cell-based research increases, the opportunities for augmentation of the cell harvesting market are expected to increase significantly in the near future.
Market Coverage
Report Elements |
Details |
Study Period |
2019-2026 |
Base year |
2019 |
Forecast period |
2020-2026 |
Segments Covered |
By Type |
Key Companies Profiled |
Amgen Inc., Novo
Nordisk A/S, CSL Ltd., Bristol-Myers Squibb Co., AstraZeneca PLC, Merck &
Co., Inc., Johnson & Johnson Services Inc., and Pfizer Inc. |
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID
o Most affected region/segment
o Recommendations
US Biotechnology Market – Segmentation
By Type
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/us-biotechnology-market